BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 34990768)

  • 1. Network pharmacology analysis and experimental validation to explore the mechanism of Shenlian extract on myocardial ischemia.
    Li JJ; Wang CM; Wang YJ; Yang Q; Cai WY; Li YJ; Song M; Zang YL; Cui XH; Li Q; Chen Y; Weng XG; Zhu XX
    J Ethnopharmacol; 2022 Apr; 288():114973. PubMed ID: 34990768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated serum pharmacochemistry with network pharmacology and pharmacological validation to elucidate the mechanism of yiqitongmai decoction (YQTMD) against myocardial infarction.
    Yu H; Wang N; Zhao X; Han L; Peng J
    J Ethnopharmacol; 2024 Sep; 331():118329. PubMed ID: 38750989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shenlian extract attenuates myocardial ischaemia-reperfusion injury via inhibiting M1 macrophage polarization by silencing
    Song M; Cui X; Zhang J; Li Y; Li J; Zang Y; Li Q; Yang Q; Chen Y; Cai W; Weng X; Wang Y; Zhu X
    Pharm Biol; 2022 Dec; 60(1):2011-2024. PubMed ID: 36239618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shenlian extract improves atherosclerosis by relieving adventitial inflammation.
    Han S; Nie C; Wang C; Song M; Li J; Cui X; Yang Q; Li Y; Chen Y; Li Q; Cai W; Weng X; Wang Y; Zhu X
    J Ethnopharmacol; 2024 Feb; 320():117339. PubMed ID: 37866468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Integrated Analysis of Network Pharmacology and Experimental Validation to Reveal the Mechanism of Chinese Medicine Formula Naotaifang in Treating Cerebral Ischemia-Reperfusion Injury.
    Yang T; Chen X; Mei Z; Liu X; Feng Z; Liao J; Deng Y; Ge J
    Drug Des Devel Ther; 2021; 15():3783-3808. PubMed ID: 34522084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated network pharmacology to investigate the mechanism of Salvia miltiorrhiza Bunge in the treatment of myocardial infarction.
    Huang X; Zhang M; Song Y; Sun B; Lin L; Song X; Li C
    J Cell Mol Med; 2023 Nov; 27(22):3514-3525. PubMed ID: 37643320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating network pharmacology and experimental evidence to decipher the cardioprotective mechanism of Yiqihuoxue decoction in rats after myocardial infarction.
    Li FH; Guo SW; Zhan TW; Mo HR; Chen X; Wang H; Wei LL; Feng PF; Wu JG; Li P
    J Ethnopharmacol; 2021 Oct; 279():114062. PubMed ID: 33771641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and identification of the components in Cybister chinensis Motschulsky against inflammation and their mechanisms of action based on network pharmacology and molecular docking.
    Che YH; Xu ZR; Ni LL; Dong XX; Yang ZZ; Yang ZB
    J Ethnopharmacol; 2022 Mar; 285():114851. PubMed ID: 34808299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular mechanism of Dalbergia cochinchinensis heartwood in regulation of energy metabolism to treat myocardial ischemia based on network pharmacology and experimental validation].
    Cheng LH; Chen LY; Shou BY; Luo YY; Cui YR; Liu RH
    Zhongguo Zhong Yao Za Zhi; 2022 Dec; 47(24):6696-6708. PubMed ID: 36604920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating Network Pharmacology and an Experimental Model to Investigate the Effect of Zhenwu Decoction on Doxorubicin-Induced Heart Failure.
    Hu Y; Qu H; Zhou H
    Comb Chem High Throughput Screen; 2023; 26(14):2502-2516. PubMed ID: 37056062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated strategy of network pharmacology, molecular docking, HPLC-DAD and mice model for exploring active ingredients and pharmacological mechanisms of Penthorum chinense Pursh against alcoholic liver injury.
    Jiang Y; Zhong M; Zhan H; Tao X; Zhang Y; Mao J; Geng Z; Gao B
    J Ethnopharmacol; 2022 Nov; 298():115589. PubMed ID: 35926779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating UPLC-Q-Exactive Orbitrap/MS, network pharmacology and experimental validation to reveal the potential mechanism of Tibetan medicine Rhodiola granules in improving myocardial ischemia-reperfusion injury.
    Xing N; Qin J; Ren D; Du Q; Li Y; Mi J; Zhang F; Ai L; Zhang S; Zhang Y; Wang S
    J Ethnopharmacol; 2023 Oct; 314():116572. PubMed ID: 37201662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Identification of traditional Chinese drugs containing active ingredients for treating myocardial infarction and analysis of their therapeutic mechanisms by network pharmacology and molecular docking].
    Zhao S; Liu K; Duan J; Tao X; Li W; Bai Y; Wei P; Xi M; Yang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jan; 42(1):13-25. PubMed ID: 35249866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Network pharmacology exploration reveals a common mechanism in the treatment of cardio-cerebrovascular disease with Salvia miltiorrhiza Burge. and Carthamus tinctorius L.
    Wang Y; Shi Y; Zou J; Zhang X; Liang Y; Tai J; Cui C; Wang M; Guo D
    BMC Complement Med Ther; 2020 Nov; 20(1):351. PubMed ID: 33213432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
    Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
    J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shenlian extract protects against ultrafine particulate matter-aggravated myocardial ischemic injury by inhibiting inflammation response via the activation of NLRP3 inflammasomes.
    Qu S; Li K; Yang T; Yang Y; Zheng Z; Liu H; Wang X; Zhang Y; Deng S; Zhu X; Chen L; Li Y
    Environ Toxicol; 2021 Jul; 36(7):1349-1361. PubMed ID: 33729688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated chemical profiling, network pharmacology and pharmacological evaluation to explore the potential mechanism of Xinbao pill against myocardial ischaemia-reperfusion injury.
    Yang Y; Chen T; Liu J; Chen S; Cai R; Wu L; Hu J; Lin Q; Qi X; Liu Z; Cheng Y
    Pharm Biol; 2022 Dec; 60(1):255-273. PubMed ID: 35148221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shenlian extract decreases mitochondrial autophagy to regulate mitochondrial function in microvascular to alleviate coronary artery no-reflow.
    Li JJ; Wang YJ; Wang CM; Li YJ; Yang Q; Cai WY; Chen Y; Zhu XX
    Phytother Res; 2023 May; 37(5):1864-1882. PubMed ID: 36740450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the mechanisms underlying the therapeutic effect of Salvia miltiorrhiza in diabetic nephropathy using network pharmacology and molecular docking.
    Zhang L; Han L; Wang X; Wei Y; Zheng J; Zhao L; Tong X
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 33634308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network pharmacology and experimental validation to investigate the mechanism of Nao-Ling-Su capsule in the treatment of ischemia/reperfusion-induced acute kidney injury.
    Lin Y; Xu L; Lin H; Cui W; Jiao Y; Wang B; Li H; Wang X; Wu J
    J Ethnopharmacol; 2024 May; 326():117958. PubMed ID: 38395179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.